Get the Stockscreener App
6.41
31.62%
1.54
Diamedica Therapeutics Inc Stock (DMAC) Forecast
The Diamedica Therapeutics Inc (DMAC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.3641, representing a -47.52% decrease from the current price of $6.41. The highest analyst price target is $4.5926, and the lowest is $2.1357.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DMAC Price Target
Average 4.7739
(-25.52% Downside)
Is Diamedica Therapeutics Inc (DMAC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 69.51 | Neutral |
| STOCH(9,6) | 41.07 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.2416 | Buy |
| ADX(14) | 23.13 | Neutral |
| William %R | 0.00 | Sell |
| CCI(14) | 91.62 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.355
Buy
|
5.3797
Buy
|
| MA20 |
5.293
Buy
|
5.1996
Buy
|
| MA50 |
4.6854
Buy
|
4.8063
Buy
|
| MA100 |
4.331
Buy
|
4.3869
Buy
|
| MA200 |
3.6059
Buy
|
3.8761
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, DMAC could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on DMAC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 69.51 indicates that DMAC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 41.07 indicates that DMAC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that DMAC is oversold. This suggests that DMAC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.13 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 91.62 indicates that DMAC is still overbought but not to an extreme extent.
Long-term DMAC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Diamedica Therapeutics Inc financial reports and earnings history, Diamedica Therapeutics Inc (DMAC) stock could reach $2.0415 by 2030, $0.2493 by 2040 and $0.1441 by 2050. See the projected annual prices until 2050 of the Diamedica Therapeutics Inc stock below:
- Diamedica Therapeutics Inc (DMAC) is expected to reach an average price of $1.593 in 2035, with a high prediction of $1.7205 and a low estimate of $1.0597. This indicates an $-75.15% rise from the last recorded price of $6.41.
- Diamedica Therapeutics Inc (DMAC) stock is projected to chart a bullish course in 2040, with an average price target of $0.0318, representing an $-99.50% surge from its current level. The forecast ranges from a conservative $0.000543 to a sky-high $0.2493.
- Our analysts predict Diamedica Therapeutics Inc (DMAC) to jump -86.17% by 2045, soaring from $0.8763 to an average price of $0.8863, potentially reaching $0.898. While $0.8763 is the low estimate, the potential upside is significant.
- Diamedica Therapeutics Inc (DMAC) stock is expected to climb by 2050, reaching an average of $0.062, a $-99.03% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.1441 and $0.2783, respectively, highlighting the market's uncertainty.
Diamedica Therapeutics Inc Stock (DMAC) Year by Year Forecast
Diamedica Therapeutics Inc Stock (DMAC) Price Forecast for 2025
Diamedica Therapeutics Inc Stock (DMAC) is expected to reach an average price of $4.7739 in 2025, with a high prediction of $8.1968 and a low estimate of $1.351. This indicates an -25.52% fall from the last recorded price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.1529 | $2.1357 | $4.5926 | -35.21% |
| February, 2025 | $3.7876 | $3.0918 | $4.1864 | -40.91% |
| March, 2025 | $3.7793 | $3.4193 | $5.2639 | -41.04% |
| April, 2025 | $2.0864 | $1.351 | $4.0597 | -67.45% |
| May, 2025 | $2.7431 | $1.9418 | $3.1495 | -57.21% |
| June, 2025 | $3.8947 | $2.6847 | $4.4947 | -39.24% |
| July, 2025 | $6.7091 | $3.5852 | $8.1968 | +4.67% |
| August, 2025 | $5.5485 | $5.5185 | $7.0486 | -13.44% |
| September, 2025 | $4.8502 | $4.4502 | $6.9489 | -24.33% |
| October, 2025 | $3.7023 | $3.3014 | $5.1606 | -42.24% |
| November, 2025 | $3.654 | $3.1725 | $4.0081 | -43.00% |
| December, 2025 | $3.7961 | $3.3062 | $4.4148 | -40.78% |
Diamedica Therapeutics Inc Stock (DMAC) Price Forecast for 2026
The predicted value for Diamedica Therapeutics Inc (DMAC) in 2026 is set at an average of $6.3588. Estimates vary from a peak of $10.29 to a trough of $2.4245, indicating an -0.80% surge from the present price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.1577 | $3.4565 | $5.5077 | -19.54% |
| February, 2026 | $6.7594 | $4.2086 | $7.0604 | +5.45% |
| March, 2026 | $9.4511 | $6.7298 | $9.9307 | +47.44% |
| April, 2026 | $9.8432 | $7.0419 | $10.29 | +53.56% |
| May, 2026 | $9.4149 | $6.734 | $10.05 | +46.88% |
| June, 2026 | $9.3265 | $8.3857 | $10.13 | +45.50% |
| July, 2026 | $5.9186 | $5.6686 | $9.377 | -7.67% |
| August, 2026 | $8.3803 | $5.8895 | $8.5803 | +30.74% |
| September, 2026 | $3.5724 | $3.1324 | $8.9707 | -44.27% |
| October, 2026 | $2.8041 | $2.5937 | $3.6328 | -56.25% |
| November, 2026 | $3.7258 | $2.4245 | $3.9158 | -41.88% |
| December, 2026 | $3.4379 | $3.037 | $4.2479 | -46.37% |
Diamedica Therapeutics Inc Stock (DMAC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Diamedica Therapeutics Inc (DMAC) is $2.4142, with a high forecast of $4.2308 and a low forecast of $0.5976. This indicates an -62.34% decrease from the last price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4195 | $3.2788 | $3.7783 | -46.65% |
| February, 2027 | $3.2512 | $3.0112 | $4.2308 | -49.28% |
| March, 2027 | $2.9833 | $2.7154 | $3.4433 | -53.46% |
| April, 2027 | $2.815 | $2.705 | $3.3746 | -56.08% |
| May, 2027 | $2.2067 | $1.6358 | $2.7854 | -65.57% |
| June, 2027 | $1.8888 | $1.8586 | $2.6625 | -70.53% |
| July, 2027 | $1.9404 | $1.6396 | $2.4989 | -69.73% |
| August, 2027 | $1.7521 | $1.5621 | $2.0513 | -72.67% |
| September, 2027 | $1.8842 | $1.6234 | $2.153 | -70.61% |
| October, 2027 | $1.5959 | $1.4959 | $1.9555 | -75.10% |
| November, 2027 | $0.7976 | $0.5976 | $1.7863 | -87.56% |
| December, 2027 | $1.4197 | $0.678 | $1.4297 | -77.85% |
Diamedica Therapeutics Inc Stock (DMAC) Price Forecast for 2028
In 2028, Diamedica Therapeutics Inc (DMAC) is projected to reach an average price of $2.3989, with a high projection of $4.2215 and a low estimate of $0.5764. This indicates an -62.58% fall from the last price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2113 | $1.1305 | $1.4501 | -81.10% |
| February, 2028 | $0.693 | $0.6526 | $1.2418 | -89.19% |
| March, 2028 | $0.6351 | $0.6034 | $1.0143 | -90.09% |
| April, 2028 | $0.6368 | $0.5764 | $0.7658 | -90.07% |
| May, 2028 | $1.0089 | $0.5872 | $1.2585 | -84.26% |
| June, 2028 | $1.0306 | $0.8597 | $1.1206 | -83.92% |
| July, 2028 | $0.8422 | $0.7322 | $1.0409 | -86.86% |
| August, 2028 | $1.1543 | $0.8427 | $1.3243 | -81.99% |
| September, 2028 | $1.086 | $0.9256 | $1.3648 | -83.06% |
| October, 2028 | $1.1277 | $0.9673 | $1.3164 | -82.41% |
| November, 2028 | $2.0698 | $1.0481 | $2.6389 | -67.71% |
| December, 2028 | $3.7915 | $2.0102 | $4.2215 | -40.85% |
Diamedica Therapeutics Inc Stock (DMAC) Price Forecast for 2029
The 2029 price forecast for Diamedica Therapeutics Inc Stock (DMAC) is $2.6693 on average, with a high prediction of $3.9219 and a low estimate of $1.4168. This represents an -58.36% decrease from the previous price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.8536 | $2.4731 | $3.9219 | -55.48% |
| February, 2029 | $2.3452 | $2.134 | $2.94 | -63.41% |
| March, 2029 | $2.7169 | $2.3257 | $3.0269 | -57.61% |
| April, 2029 | $1.5286 | $1.4168 | $2.7173 | -76.15% |
| May, 2029 | $1.8407 | $1.529 | $2.2403 | -71.28% |
| June, 2029 | $2.0724 | $1.6011 | $2.3336 | -67.67% |
| July, 2029 | $2.324 | $2.0128 | $2.5532 | -63.74% |
| August, 2029 | $2.3061 | $2.0561 | $2.5649 | -64.02% |
| September, 2029 | $2.3178 | $2.2267 | $2.7872 | -63.84% |
| October, 2029 | $2.2399 | $1.9299 | $2.8299 | -65.06% |
| November, 2029 | $1.8816 | $1.7816 | $2.6907 | -70.65% |
| December, 2029 | $1.96 | $1.752 | $2.33 | -69.42% |
Diamedica Therapeutics Inc Stock (DMAC) Price Forecast for 2030
Diamedica Therapeutics Inc Stock (DMAC) is expected to reach an average price of $2.5676 in 2030, with a high forecast of $4.675 and a low forecast of $0.4601. This signifies an -59.94% decrease from the last price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.6967 | $1.3334 | $2.0415 | -73.53% |
| February, 2030 | $3.3375 | $1.5737 | $4.675 | -47.93% |
| March, 2030 | $2.1709 | $2.0209 | $3.4057 | -66.13% |
| April, 2030 | $1.6543 | $1.1402 | $2.4217 | -74.19% |
| May, 2030 | $0.827 | $0.7784 | $1.8551 | -87.10% |
| June, 2030 | $1.8727 | $0.4601 | $1.9118 | -70.78% |
| July, 2030 | $2.0985 | $1.3643 | $2.646 | -67.26% |
| August, 2030 | $2.5493 | $1.4077 | $3.0693 | -60.23% |
| September, 2030 | $3.279 | $2.6702 | $3.9777 | -48.85% |
| October, 2030 | $3.4362 | $2.4785 | $3.7811 | -46.39% |
| November, 2030 | $2.3802 | $2.2802 | $4.6527 | -62.87% |
| December, 2030 | $1.6136 | $0.7419 | $2.3811 | -74.83% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):